Trials / Completed
CompletedNCT02121262
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients With Diabetic Macular Edema
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 284 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of 700 μg dexamethasone versus laser photocoagulation in participants with diabetic macular edema (DME).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | Dexamethasone 700 μg intravitreal injection in the study eye on Day 1, Months 5, and 10. |
| PROCEDURE | Laser Photocoagulation | Laser photocoagulation on Day 1, and on Months 3, 6, and 9, if retreatment indicated. |
Timeline
- Start date
- 2016-01-08
- Primary completion
- 2019-11-01
- Completion
- 2019-11-01
- First posted
- 2014-04-23
- Last updated
- 2020-11-17
- Results posted
- 2020-11-17
Locations
18 sites across 2 countries: China, Philippines
Source: ClinicalTrials.gov record NCT02121262. Inclusion in this directory is not an endorsement.